Google
INCR — INC RESEARCH HOLDINGS INC (Healthcare >> Drug Manufacturers - Specialty & Generic)
INCR FAQ
What is INCR's P/E ratio?
INC RESEARCH HOLDINGS INC (INCR) currently trades at a P/E ratio of 80.13.
What is INCR's ROE?
INC RESEARCH HOLDINGS INC reports a Return on Equity (ROE) of -8.98%.
What is INCR's dividend yield?
INC RESEARCH HOLDINGS INC offers a dividend yield of 0.00%.
What is INCR's Deepscope Quality Score?
Deepscope rates INCR's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy INCR?
Deepscope's AI Timing Score for INCR is 6 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does INCR belong to?
INC RESEARCH HOLDINGS INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.
|
USD 1.03
Price
0.01
(0.97%)
Day Change
|
|
|---|
INCR, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 92 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.03 |
| PBV / Sector |
0.14 / 2.74
GREAT
|
| Earning Per Share | -0.64 |
| PE / Sector |
80.13 / 23.29
|
| PEG or PE/Growth / Sector |
-0.83 / 0.11
|
| Average 1M Daily Value |
0.03 M
GREAT
|
| Average 1W Daily Value |
0.08 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
50% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-03 09:11:40 |
| Symbol | INCR |
| Name | INC RESEARCH HOLDINGS INC |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 54.68 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 57.42 / 9,635.82 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 85 Medinat ha-Yehudim Street, Herzliya, Israel, 4676670
Phone: 972 7 746 05012
Website: https://www.intercure.co
Employees: 285
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
